Avance Clinical, formerly CPR Pharma Services, had its genesis in the University of South Australia in the early 1980s as the Centre for Pharmaceutical Research, when a group of academic scientists began providing clinical research and bioanalytical services to the local pharmaceutical industry.
Since then, we have steadily grown to become a significant Australian Contract Research Organisation, servicing both the local and international drug development industry.
In 2009, CPR Pharma Services Pty Ltd was incorporated and commenced operating independently of the University of South Australia as an Australian Contract Research Organisation. With an experienced management team, and senior staff backed by some of Australia’s leading pharmaceutical industry consultants, CPR developed a reputation as a reputable provider of clinical research services, data/biostatistical services, and bioanalytical services. In January 2019, CPR business was split into Avance Clinical and Agilex Biolabs.
Our People, Our Team
Avance Clinical’s culture of responsive customer service, coupled with stringent oversight of clinical trials can only be delivered through highly experienced industry experts.
As one of Australia’s leading Contract Research Organisations, we facilitate quality drug development by aligning our people, their skills, and expertise in the pursuit of a healthier world. We are committed to providing high-quality clinical research services and we achieve this through having a highly experienced team.
The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of candidates who demonstrate passion and expertise in their chosen field.
Please peruse our website to learn more about Avance Clinical and our team of experts, or contact us directly to discuss your specific requirements.
Avance Clinical has a global client portfolio from small to medium to large pharma offering our clients a suite of in-house clinical research services.
“Working with the Avance Team has helped us to develop and complete high quality and compliant clinical studies. I especially appreciate their penchant for communication, quality and pragmatism.”
– Sr. Vice President, Regulatory, Quality & Clinical Affairs
Atossa Genetics, Inc.